MESOBLAST CHIEF EXECUTIVE HONOURED AT THE VATICAN WITH INAUGURAL PONTIFICAL AWARD FOR INNOVATION

MESOBLAST CHIEF EXECUTIVE HONOURED AT THE VATICAN WITH INAUGURAL PONTIFICAL
AWARD FOR INNOVATION

NEW YORK and MELBOURNE, Australia, April 12, 2013 (GLOBE NEWSWIRE) --
Regenerative medicine company Mesoblast Limited (ASX:MSB, USOTC:MBLTY) is
pleased to announce that its Chief Executive Professor Silviu Itescu today
received the inaugural 'Key Innovation Award 2013' from the Pontifical Council
for Culture and The Stem for Life Foundation. This unique recognition was
announced during the Second International Vatican Adult Stem Cell
Conferencecurrently being held in Vatican City.

The award was presented by Monsignor Tomasz Trafny, Head of the Science and
Faith Department at the Pontifical Council for Culture, and Dr Robin Smith,
President for the Stem for Life Foundation. Dr Smith said the award was being
given "with admiration ofProfessor Itescu'sleadership and ingenuity in
translational science and clinical medicine within the field of adult stem
cell therapy.

"In every emerging industry, there are always individuals who stand out as
pioneers. Professor Itescu has distinguished himself as an innovator in the
field of regenerative medicine, one that has brought hope and healing to a
world struggling to manage chronic disease and serious medical conditions."

"I am honoured to have received such a distinguished award", Professor Itescu
said. "It signifies important recognition of the contributions made by the
dedicated team at Mesoblast striving to deliver safe and effective new
therapies at the forefront of regenerative medicine".

Mesoblast's achievements using its allogeneic adult stem cell technology
platform in various conditions, including cardiovascular diseases, will be
highlighted at the conference byDr Emerson C. Perin,Director, Clinical
Research for Cardiovascular Medicine and Medical Director, Stem Cell Center,
Texas Heart Institute,and Mesoblast'sChief Medical Officer, Dr Donna
Skerrett.

The Second International Vatican Adult Stem Cell Conference, entitled
RegenerativeMedicine:a Fundamental Shift in Science & Culture, is being held
within The Vatican, from 11-13 April 2013. The event is part of a five-year
collaboration betweenThe Vatican's Pontifical Council for Culture and its
Foundation, called STOQ International (Science, Theology and the Ontological
Quest),The Stem for Life Foundation, a not-for-profit organization devoted to
raising global awareness of the therapeutic potential of adult stem cells, and
NeoStem Inc.

Mesoblast Limited

Mesoblast Limited is a world leader in the development of biologic products
for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal
Precursor Cell (MPC) technology is being developed for an extensive range of
major clinical diseases, including inflammatory and immunologic conditions of
the joints and lungs, diabetes and kidney disease, orthopedic spine
conditions, and cardiovascular disorders. www.mesoblast.com

CONTACT: Julie Meldrum
         Global Head of Corporate Communications
         Mesoblast Limited
         +61396396036
         +61419228128
 
Press spacebar to pause and continue. Press esc to stop.